HOCPY saw its Momentum Indicator move above the 0 level on January 07, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for HOCPY just turned positive on January 08, 2025. Looking at past instances where HOCPY's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOCPY advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOCPY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HOCPY broke above its upper Bollinger Band on January 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HOCPY entered a downward trend on January 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOCPY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.057) is normal, around the industry mean (23.475). P/E Ratio (34.843) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.007) settles around the average of (0.018) among similar stocks. P/S Ratio (7.987) is also within normal values, averaging (41.274).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, HOCPY has been loosely correlated with TRUMY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HOCPY jumps, then TRUMY could also see price increases.
Ticker / NAME | Correlation To HOCPY | 1D Price Change % | ||
---|---|---|---|---|
HOCPY | 100% | +1.89% | ||
TRUMY - HOCPY | 51% Loosely correlated | -0.95% | ||
SSMXY - HOCPY | 44% Loosely correlated | -1.53% | ||
OLYMY - HOCPY | 32% Poorly correlated | +0.14% | ||
HOCPF - HOCPY | 27% Poorly correlated | N/A | ||
STSS - HOCPY | 27% Poorly correlated | -1.60% | ||
More |